Twist Bioscience And IMIDomics Collaborate To Discover Antibodies For Applications In Immune-Mediated Inflammatory Diseases
Portfolio Pulse from Benzinga Newsdesk
Twist Bioscience and IMIDomics have announced a collaboration to discover antibodies for applications in immune-mediated inflammatory diseases. The partnership will leverage Twist Bioscience's proprietary antibody discovery platform.
September 27, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Twist Bioscience's partnership with IMIDomics could potentially lead to the discovery of new antibodies, which could enhance its product portfolio and potentially increase its revenues.
The partnership with IMIDomics allows Twist Bioscience to leverage its proprietary antibody discovery platform to potentially discover new antibodies. This could lead to the development of new products, which could increase the company's revenues and positively impact its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100